YKL069W Antibody

What is YKL069W and why would researchers need antibodies against it?

YKL069W (also known as fRMsr or YKG9) is a verified open reading frame in Saccharomyces cerevisiae that encodes a methionine-R-sulfoxide reductase. This enzyme specifically reduces the R enantiomer of free methionine sulfoxide (Met-SO), distinguishing it from Ycl033Cp (MsrB), which reduces Met-R-SO in peptide linkages . YKL069W plays a significant role in protecting yeast cells against oxidative stress.

Researchers would need antibodies against YKL069W for several important applications:

• Detecting and quantifying YKL069W protein expression levels

• Investigating its subcellular localization

• Studying protein-protein interactions

• Examining how oxidative stress affects YKL069W levels and activity

• Comparing expression across different growth conditions or mutant strains

What structural features of YKL069W should be considered when developing antibodies?

When developing antibodies against YKL069W, researchers should consider several key structural features:

• Catalytic cysteine residues: YKL069W contains three critical cysteine residues (C91, C101, and C125) that are essential for its enzymatic function . Antibodies targeting regions containing these residues might affect protein function or have reduced binding depending on the protein's redox state.

• Protein size and accessibility: YKL069W is encoded by coordinates Chr XI:307285..307827, resulting in a relatively small protein . Ensuring antibodies target accessible epitopes is crucial.

• Sequence homology: Consider the similarity to other methionine sulfoxide reductases when selecting epitopes to avoid cross-reactivity.

How can I validate the specificity of a YKL069W antibody in yeast samples?

Validating the specificity of YKL069W antibodies requires several complementary approaches:

• Use of knockout controls: Compare wild-type yeast samples with fRMsr deletion mutants in Western blots or immunoprecipitation experiments. The antibody signal should be absent or significantly reduced in deletion strains .

• Recombinant protein controls: Express and purify recombinant YKL069W (with appropriate tags) to use as a positive control.

• Pre-absorption tests: Pre-incubate the antibody with purified YKL069W protein before immunodetection. This should eliminate specific signals if the antibody is truly specific.

• Mass spectrometry verification: After immunoprecipitation with the YKL069W antibody, analyze the captured proteins by mass spectrometry to confirm identity.

• Mutant variants analysis: Test antibody reactivity against samples containing C91S, C101S, or C125S variants of YKL069W to assess epitope specificity .

What are the recommended fixation and sample preparation methods for immunodetection of YKL069W?

For optimal immunodetection of YKL069W in yeast samples:

For Western blotting:

• Extract proteins using mechanical disruption (glass beads) in buffer containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, and protease inhibitors.

• Include reducing agents (DTT or β-mercaptoethanol) to preserve the native state of the catalytic cysteines.

• Add alkylating agents to prevent non-specific disulfide formation during sample preparation.

For immunofluorescence microscopy:

• Fix cells with 4% paraformaldehyde for 15-30 minutes.

• Permeabilize cell wall with zymolyase treatment followed by membrane permeabilization with 0.1% Triton X-100.

• Block with BSA or normal serum to reduce background.

For immunoprecipitation:

• Use mild lysis conditions to preserve protein-protein interactions.

• Consider crosslinking approaches if studying transient interactions with oxidized proteins or thioredoxin.

Can YKL069W antibodies be used for both Western blotting and immunofluorescence studies?

Whether YKL069W antibodies can be used for both Western blotting and immunofluorescence depends on the specific antibody characteristics:

• Epitope recognition: Antibodies recognizing linear epitopes work well for Western blotting but may fail in immunofluorescence where proteins retain their native conformation.

• Antibody class: Polyclonal antibodies often work across multiple applications but with variable specificity. Monoclonal antibodies may be more specific but limited to certain applications.

• Validation testing: Each new antibody should be validated separately for each intended application.

How do the catalytic cysteine residues (C91, C101, and C125) in YKL069W affect epitope selection for antibody development?

The catalytic cysteine residues in YKL069W present specific challenges for antibody development:

• Conformational states: These cysteines undergo redox-dependent conformational changes during the catalytic cycle. Antibodies targeting regions containing these residues may show differential binding depending on the oxidation state of the protein .

• Epitope accessibility: Studies using site-directed mutagenesis have shown that C91, C101, and C125 play different roles in the catalytic mechanism. C91S, C101S, and C125S mutants exhibit different interactions with thioredoxin, suggesting these regions undergo significant structural changes during catalysis .

• Recommended approach: For detection of total YKL069W regardless of activity state, design antibodies against regions distant from these catalytic residues. For studying specific redox states, consider developing conformation-specific antibodies that preferentially recognize oxidized or reduced forms.

The data from mutational studies can guide epitope selection:

What are the best approaches for generating antibodies that can distinguish between active and oxidized forms of YKL069W?

Generating antibodies that distinguish between active and oxidized forms of YKL069W requires specialized approaches:

• Redox-state specific immunogens:

  • For reduced (active) form: Generate immunogens in the presence of strong reducing agents and alkylate free thiols to lock the protein in the reduced state.

  • For oxidized form: Create immunogens with oxidized cysteines, potentially through hydrogen peroxide treatment under controlled conditions.

• Peptide-based approach: Design synthetic peptides that mimic the conformation of specific regions around C91, C101, and C125 in either reduced or oxidized states.

• Screening methodology: Develop a differential screening protocol that selects antibodies showing significantly different binding to reduced versus oxidized YKL069W.

• Validation strategy: Validate antibody specificity using wild-type YKL069W exposed to oxidative stress compared to the C91S, C101S, and C125S mutants, which would disrupt normal redox cycling .

How can I design experiments to study the interaction between YKL069W and thioredoxin using antibody-based techniques?

YKL069W interacts with thioredoxin as part of its catalytic cycle. The following experimental approaches can be used to study this interaction:

• Co-immunoprecipitation (Co-IP):

  • Perform reciprocal Co-IPs using antibodies against YKL069W and thioredoxin.

  • Include appropriate controls (e.g., C35S thioredoxin mutant as shown in the cited research) .

  • Compare interactions under normal and oxidative stress conditions.

• Proximity ligation assay (PLA):

  • Use antibodies against YKL069W and thioredoxin to visualize interactions in situ.

  • Quantify interaction signals under different redox conditions.

• FRET-based approaches:

  • Use antibody fragments conjugated to fluorophores for detecting proximity between YKL069W and thioredoxin.

• Trapping intermediates:

  • Utilize the C35S thioredoxin mutant-immobilized resin approach described in the research to trap resolving cysteines of fRMsr .

  • Monitor complex formation using specific antibodies against YKL069W.

Sample experimental design table:

What are the challenges in developing antibodies that can distinguish between YKL069W (fRMsr) and other methionine sulfoxide reductases like MsrA and MsrB?

Developing antibodies that specifically recognize YKL069W without cross-reactivity to other methionine sulfoxide reductases presents several challenges:

• Functional similarity: YKL069W (fRMsr), MsrA, and MsrB all catalyze the reduction of methionine sulfoxide but with different substrate specificities. fRMsr reduces free Met-R-SO, while MsrA reduces Met-S-SO, and MsrB reduces Met-R-SO in peptide linkages .

• Sequence and structural homology: Despite functional relationships, these proteins have distinct sequences and structures that can be leveraged for specific antibody development.

• Epitope selection strategy:

  • Perform detailed sequence alignment of YKL069W, MsrA, and MsrB to identify regions with minimal homology.

  • Focus on unique structural features of YKL069W not present in other Msrs.

  • Consider raising antibodies against synthetic peptides derived from unique regions.

• Validation approach:

  • Test antibodies against recombinant YKL069W, MsrA, and MsrB proteins.

  • Evaluate cross-reactivity in lysates from wild-type yeast and single/double deletion mutants (ΔfRMsr, ΔMsrA, ΔMsrB, ΔfRMsr/ΔMsrA) .

How can I use YKL069W antibodies to study the role of this protein in oxidative stress response pathways?

YKL069W antibodies can be powerful tools for studying oxidative stress response pathways:

• Expression level analysis:

  • Monitor YKL069W protein levels under different oxidative stress conditions (H₂O₂, paraquat, etc.) using quantitative Western blotting.

  • Compare expression in wild-type cells versus cells with mutations in oxidative stress response pathways.

• Subcellular localization:

  • Track potential changes in YKL069W localization during oxidative stress using immunofluorescence.

  • Combine with markers for cellular compartments to detect redistribution.

• Protein-protein interactions:

  • Use immunoprecipitation with YKL069W antibodies followed by mass spectrometry to identify interaction partners that change under oxidative stress.

  • Validate key interactions using co-immunoprecipitation and proximity ligation assays.

• Post-translational modifications:

  • Develop modification-specific antibodies to detect oxidized forms of YKL069W.

  • Use these in combination with general YKL069W antibodies to calculate the ratio of oxidized/reduced protein.

• Functional studies:

  • Combine antibody-based detection with viability assays in wild-type and ΔfRMsr strains exposed to H₂O₂ .

  • Correlate YKL069W protein levels with cell survival rates.

What controls should be included when using YKL069W antibodies in research?

Proper experimental controls are critical when using YKL069W antibodies:

• Genetic controls:

  • ΔfRMsr strain lysates as negative controls for antibody specificity

  • YKL069W overexpression samples as positive controls

  • Site-directed mutants (C91S, C101S, C125S) to assess epitope-specific binding

• Technical controls:

  • Primary antibody omission to assess secondary antibody specificity

  • Isotype controls to evaluate non-specific binding

  • Pre-immune serum (for polyclonal antibodies) to establish baseline reactivity

• Sample preparation controls:

  • Reducing and non-reducing conditions to evaluate redox sensitivity

  • Different fixation methods to optimize epitope accessibility

• Expression controls:

  • Compare YKL069W expression under different nutrient and oxygen conditions, as microarray data indicates variable expression under different nutrient-limiting conditions and oxygen availability

How can I optimize antibody concentration for different experimental applications?

Optimizing antibody concentration is essential for balancing signal strength and specificity:

• Western blotting optimization:

  • Perform titration experiments using dilution series (typically 1:100 to 1:10,000)

  • Start with manufacturer's recommended dilution if available

  • Test multiple incubation times and temperatures

  • Optimize blocking conditions to improve signal-to-noise ratio

• Immunofluorescence optimization:

  • Begin with higher concentrations than used for Western blotting (typically 1:50 to 1:500)

  • Test different fixation and permeabilization protocols

  • Include antigen retrieval steps if necessary

  • Evaluate different mounting media to reduce background fluorescence

• Immunoprecipitation optimization:

  • Determine the minimum amount of antibody required for efficient pull-down

  • Test different antibody-to-bead ratios

  • Optimize washing stringency to balance specificity and yield

• Quantitative considerations:

  • For quantitative applications, ensure antibody concentration is within the linear range of detection

  • Validate linearity using purified recombinant YKL069W protein standards

What are the best approaches for quantifying YKL069W expression levels in comparative studies?

For reliable quantification of YKL069W expression levels in comparative studies:

• Western blot quantification:

  • Use internal loading controls (e.g., actin, GAPDH) for normalization

  • Include a standard curve of recombinant YKL069W protein

  • Utilize digital image analysis software for densitometry

  • Ensure exposure times are within the linear range of detection

• ELISA-based quantification:

  • Develop sandwich ELISA using two antibodies recognizing different epitopes of YKL069W

  • Include standard curves of purified YKL069W protein

  • Normalize to total protein concentration determined by BCA or Bradford assay

• Flow cytometry:

  • Use permeabilized yeast cells and fluorescently-labeled YKL069W antibodies

  • Include appropriate isotype controls

  • Normalize to cell size/complexity parameters

• Mass spectrometry-based approaches:

  • Use stable isotope-labeled standards for absolute quantification

  • Monitor multiple peptides derived from YKL069W

  • Implement parallel reaction monitoring for enhanced specificity

Sample experimental design for comparing YKL069W expression under oxidative stress conditions:

Why might I experience high background when using YKL069W antibodies in immunofluorescence?

High background in immunofluorescence experiments with YKL069W antibodies can result from several factors:

• Yeast cell wall interference:

  • Incomplete spheroplasting may limit antibody penetration

  • Solution: Optimize zymolyase treatment conditions (concentration, time, temperature)

  • Test alternative cell wall digestion enzymes or combinations

• Fixation issues:

  • Overfixation can create autofluorescence and reduce epitope accessibility

  • Solution: Test different fixatives (paraformaldehyde, methanol) and fixation times

  • Implement antigen retrieval steps if necessary

• Antibody concentration:

  • Too high antibody concentration increases non-specific binding

  • Solution: Perform titration experiments to determine optimal concentration

  • Consider longer incubation times with more dilute antibody solutions

• Blocking inefficiency:

  • Inadequate blocking allows non-specific antibody binding

  • Solution: Try different blocking agents (BSA, normal serum, commercial blockers)

  • Increase blocking time or concentration

• Autofluorescence:

  • Yeast cells may exhibit intrinsic fluorescence, especially after oxidative stress

  • Solution: Include unstained controls to assess autofluorescence levels

  • Use spectral unmixing if available on your microscope system

How can I improve the signal-to-noise ratio when detecting YKL069W in complex protein mixtures?

To improve signal-to-noise ratio when detecting YKL069W:

• Sample preparation optimization:

  • Implement fractionation techniques to enrich for YKL069W-containing compartments

  • Use optimized lysis buffers that maintain YKL069W solubility and stability

  • Consider immunoprecipitation followed by Western blotting for low-abundance detection

• Blocking and washing optimization:

  • Test different blocking agents (milk, BSA, commercial blockers)

  • Increase washing stringency gradually until background is reduced without losing specific signal

  • Add low concentrations of detergents (0.05-0.1% Tween-20) to washing buffers

• Antibody specificity enhancement:

  • Consider affinity purification of polyclonal antibodies against recombinant YKL069W

  • Pre-absorb antibodies with yeast lysates from ΔfRMsr strains to remove cross-reactive antibodies

  • Use monoclonal antibodies for highest specificity

• Detection system optimization:

  • Compare different detection systems (HRP, fluorescent, chemiluminescent)

  • For Western blotting, try signal enhancers compatible with your detection method

  • Consider more sensitive detection methods (e.g., tyramide signal amplification) for low abundance detection

What strategies can help resolve cross-reactivity issues with YKL069W antibodies?

When facing cross-reactivity issues with YKL069W antibodies:

• Epitope analysis:

  • Determine if cross-reactivity is due to sequence homology with other proteins

  • Identify unique epitopes within YKL069W for alternative antibody development

  • Consider using antibodies against a tagged version of YKL069W in recombinant systems

• Antibody purification:

  • Perform affinity purification against the specific YKL069W epitope

  • Use negative selection against identified cross-reactive proteins

  • Consider subtractive approaches using lysates from ΔfRMsr strains

• Validation with genetic models:

  • Compare antibody reactivity in wild-type and ΔfRMsr strains

  • Test reactivity against site-directed mutants (C91S, C101S, C125S)

  • Use cells with controlled YKL069W overexpression as positive controls

• Alternative detection strategies:

  • Use multiple antibodies targeting different epitopes and look for signal overlap

  • Combine antibody detection with mass spectrometry validation

  • Consider proximity ligation assays that require two antibodies for positive signal

How are YKL069W antibodies contributing to our understanding of oxidative stress in yeast?

YKL069W antibodies have become valuable tools in advancing our understanding of oxidative stress responses in yeast:

• Mechanistic insights: These antibodies have helped elucidate the specific role of YKL069W in reducing free methionine-R-sulfoxide, distinguishing its function from MsrA and MsrB proteins .

• Redox dynamics: By enabling the detection of YKL069W under different oxidative conditions, antibodies have helped researchers track how this protein responds to and helps mitigate oxidative stress.

• Protein-protein interactions: Immunoprecipitation studies with YKL069W antibodies have revealed interaction partners, particularly thioredoxin, illuminating the regeneration mechanism for this important antioxidant enzyme .

• Subcellular localization: Immunofluorescence studies using YKL069W antibodies have helped determine where this protein functions within the cell during normal growth and under stress conditions.

• Expression regulation: Quantitative studies using these antibodies have contributed to our understanding of how YKL069W expression is regulated under different nutrient and oxygen conditions .

What are promising future research directions using YKL069W antibodies?

Several promising research directions could benefit from YKL069W antibodies:

• Systems biology approaches: Using YKL069W antibodies in proteomic studies to map the complete interactome of this protein under different stress conditions.

• Aging research: Investigating the role of YKL069W in yeast chronological and replicative aging, given the importance of oxidative stress in aging processes.

• Drug discovery: Screening for compounds that modulate YKL069W activity or expression as potential antifungal targets or as models for human Msr modulators.

• Comparative studies across species: Using antibodies with cross-species reactivity to examine conservation of fRMsr function across evolutionary distance.

• Stress adaptation mechanisms: Exploring how YKL069W contributes to adaptation to chronic oxidative stress through protein-level and post-translational regulation.

• Structural biology: Using conformation-specific antibodies to capture and study different states of YKL069W during its catalytic cycle.

• Biomarker development: Evaluating whether YKL069W levels or modifications could serve as biomarkers for oxidative stress in yeast-based bioassays.